Sorrento Therpt Cmn (NASDAQ: SRNE) drew the attention of analysts when the last trading session saw an increase of 2.36% or 0.08 points to close at 3.47 USD. A total of 2.6 million shares were traded during the day compared to the average turnover of 1.52 million shares, while its relative size is 1.71. Sorrento Therpt Cmn (NASDAQ: SRNE) has a market limit of USD 396.2 million, and the number of shares issued has been calculated at USD 114.18 million.
Sorrento Therpt Cmn shares (NASDAQ: SRNE) currently have a recommendation of the Medium Brokerage House of 1, the number of positions in ABR is 3, while the company's industry position according to ABR is currently 257). On the recommendation of analysts 1 rate Sorrento Therpt Cmn (NASDAQ: SRNE) wrestling and Buy, 2 rate the power ahead, 0 rate rate, 0 rate poor performance and 0 recommend Sell.
By taking a look at where the stock may be directed in the future, by consensus, the selling party has a 52-week price target of $ 21.67, the valuation is based on the three opinions. The most optimistic analyst notes that shares reach $ 40, while the most conventional target prices are $ 10.
Sorrento Therpt Cmn (NASDAQ: SRNE) since the last trade, showed weekly positive results of 10.86%, which remained at -12.81% in the period of one month. In the last three months, the stock dropped -35.14%, bringing six-month results to -54.04%. Annual stock performance shows an upward trend of 19.66%, and year-end results (YTD) reflect -8,68% of the negative forecast.
When analyzing finances, we can look at a number of key indicators. Sorrento Therpt Cmn (NASDAQ: SRNE) has a twelve-month return on assets of -13.6%, which is a key indicator of the company's profitability in relation to its total assets. The company currently has a return on equity of -30.6% and a return on investment of 27.4%. ROI is a measure of performance used to assess investment performance or to compare the effectiveness of a number of different investments.
Looking at profitability ratios Sorrento Therpt Cmn (NASDAQ: SRNE) has a twelve-month gross sales margin of 97%, operating margin over 12 months remains at -2.1%, while its final net profit margins over 12 months amount to -39.4%.
However, looking at the valuation ratios, the indicator has a five-year PEG-value of 0, while its final 12-month P / E ratio is 0. The price-to-profit ratio in the next financial year is 0. Sorrento Therpt Cmn (NASDAQ: SRNE) "Price per the free cash flow during the twelve months is 0. Its beta value is 2.59.
The company's quick valuation for the last quarter is 1.4 together with the current indicator for the last quarter of 1.4. The total debt-to-equity ratio in the last quarter was 0.07, while the ratio of debt to equity in the last quarter was 0.06.